Navigation Links
Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
Date:11/29/2011

xecutive officer of Omeros. "While that trial advances, we are in discussions with regulators in the United States and Europe so that we will be poised to file marketing applications as soon as possible following receipt of data, should they be positive."

Omeros' OMS302 Program

OMS302 is Omeros' PharmacoSurgery™ product candidate being developed for use during ophthalmological procedures including cataract and other lens replacement surgery. OMS302 is a proprietary combination of an anti-inflammatory active pharmaceutical ingredient (API) and an API that causes mydriasis (pupil dilation), each with well-known safety and pharmacologic profiles. FDA-approved drugs containing each of these APIs have been used in ophthalmological clinical practice for more than 15 years, and both APIs are contained in generic, FDA-approved drugs.

In a 221-subject Phase 2b clinical trial that evaluated OMS302 in patients undergoing cataract surgery, OMS302 demonstrated clinically meaningful and statistically significant benefits in both prespecified co-primary endpoints – maintenance of intraoperative mydriasis and reduction of pain in the early postoperative period. Also, fewer OMS302-treated subjects reported moderate and severe postoperative pain. In that study, OMS302 was safe and well tolerated without evidence of drug-related adverse events.

About Omeros Corporation

Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, t
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
3. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
4. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
5. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
6. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
8. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
9. Daniel K. Spiegelman Elected to Board of Directors of Omeros
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... BETHESDA, Md. , Jan. 23, 2015  Northwest Biotherapeutics, Inc. ... developing DCVax® personalized immune therapies for operable and inoperable solid ... will present at the 7 th Annual Phacilitate Immunotherapy ... NW Bio,s presentation at Phacilitate will take place on January ...
(Date:1/23/2015)... 2015  Pete Rose, baseball,s all-time hits leader, is the new ... Myoflex, Ducere Pharma has announced. "Pete,s a Hall ... have him on board with Myoflex," said Ducere Pharma Chief ... player who is known across all generations. The passion and ...
(Date:1/23/2015)... Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Proxy Statement, Schedule 14A, with the U.S. Securities & Exchange ... shareholders detailing why a "YES" vote to increase the number ... As we reflect upon the 2014 fiscal year that ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Pete Rose bets on Myoflex to relieve aches and pains 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... the leader in centralized expert evaluation of treatments for ... using MedAvante Centralized Ratings in their pivotal Phase 3 ... completion of the patient enrollment phase of their clinical ... qualified MedAvante mental health expert at every visit of ...
... InfraReDx, Inc. , a medical device ... the publication of a case report in Circulation ... core plaque as detected by its LipiScan™ Coronary Imaging ... system to provide a Chemogram™ (map of lipid core ...
Cached Medicine Technology:Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study 2Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study 3InfraReDx Announces Publication of a Case Report in Circulation Highlighting Novel Clinical Finding with LipiScan™ Coronary Imaging System 2
(Date:1/22/2015)... A study recently published in ... Medicine & Science in Sports & Exercise shows ... reduce gastrointestinal (GI) problems associated with physical strain ... the double-blind, placebo-controlled study took 10 grams of ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Recently, Weddingshe.com has ... catalog, and has announced its highest annual revenues in the ... on its popular glamorous wedding dresses. , According to the ... important wedding dress promotions for them in 2015. This point ...
(Date:1/22/2015)... January 22, 2015 Four years since the release ... which coincided with the marriage of Avasa & Matthew Love – ... which is scheduled for release through White Swan Records on February ... there is a sacred path available to all of us to ...
(Date:1/22/2015)... Mass. (PRWEB) January 22, 2015 EBSCO ... (AMA) are expanding their relationship in an effort to ... around the world. While EBSCO has long made AMA journals ... a sales agent for The JAMA Network. , ...
(Date:1/22/2015)... 22, 2015 JJsHouse.com is a famous dress ... the business announces its latest collection of wedding dresses ... most important issue is the wedding dress on your big ... a woman’s life. Every bride wants to find the most ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... CLEVELAND, May 19 DATATRAK International,Inc. (Nasdaq: DATA ... solutions for the clinical trials industry, today announced a,restructuring ... as,part of a broad and continuing initiative to make ... a member of the DATATRAK Board of,Directors and a ...
... Monitoring of Elderly People Suffering From CHF, COPD, ... Easier and More Effective With a New, ... Technology, NOERRESUNDBY, Denmark, May 19 RTX ... of interactive telehealth,monitors, which allows healthcare system integrators ...
... are now much more likely to be diagnosed with smaller ... than a decade ago, leading to a slightly higher survival ... by a UC San Diego Medical Center researcher. , Christopher ... Medical Center and the Moores UCSD Cancer Center, and a ...
... Unique ,rotate to advance, device enables deeper enteroscopy, ... Inc., (http://www.spirusmed.com ), a leading developer of diagnostic ... at,Digestive Disease Week 2008 that it has received ... for use with its Endo-Ease Discovery SB,device in ...
... end of endoscope allows immediate imagery of gastrointestinal tract ... microscopic technique called confocal laser endomicroscopy (CLE) could lead ... as cancer, reflux disease, and inflammatory bowel disease. , ... May 18 at the Digestive Disease Week conference in ...
... Louis, May 18, 2008 Researchers at Washington University ... new type of immune response that is activated in ... disease). Their discovery could dramatically improve diagnosis and treatment ... the first part of the molecular code that links ...
Cached Medicine News:Health News:DATATRAK Announces Restructured Senior Management Team 2Health News:DATATRAK Announces Restructured Senior Management Team 3Health News:DATATRAK Announces Restructured Senior Management Team 4Health News:RTX Healthcare Launch Wireless Telehealth Monitor With Built-in GSM/GPRS Mobile Phone Technology 2Health News:Majority of kidney cancers diagnosed at earliest stage 2Health News:Spirus Medical Announces 510(k) Clearance from FDA for Expanded Use of Endo-Ease(R) Discovery SB(TM) 2Health News:New Technology Speeds GI Disease Diagnosis 2Health News:New Technology Speeds GI Disease Diagnosis 3Health News:Personalized therapy for asthma and COPD could soon be here 2Health News:Personalized therapy for asthma and COPD could soon be here 3Health News:Personalized therapy for asthma and COPD could soon be here 4
... in automatic slide stainers. It offers a ... staining, ending messy procedures. The instrument of ... and other body fluids. With the optional ... superb cytocentrifuge with eight-slide capacity and full ...
HMS 760 Robot Stainer. Version includes display....
Cholesterol, Total. An automated analyzer test kits....
For the quantitative determination of total cholesterol in serum....
Medicine Products: